SlideShare una empresa de Scribd logo
1 de 17
SPINOS LIFESCIENCEANDRESEARCHPVT LTD
1
To Be The Topmost Trusted Regulatory
Compliant Clinical Research Organization
VISION
2
Touch base with at least 50
International Pharmaceutical
Companies by 2028
Obtain UKMHRA/EMEA/GCC
regulatory approvals in next five
years of time
3
Exceed customer expectation
in terms of quality and
timeline.
M
ISSION
OURSERVICES
BIOAVAILABILITY / BIOEQUIVALENCE STUDIES
CLINICAL TRIAL (Phase I to Phase IV)
Real World Evidence Data collection
&
Registry Studies
NUTRACEUTICAL TRIALS
PROOF OF CONCEPT
STUDIES
MEDICAL DEVICE
TRIALS
4
THERAPEUTICS EXPERTISE
Oncology.
Anti-diabetic.
Anti-viral.
Anti – malarial.
Anti-depreseant
Anti-inflammatory.
Anti-tubercular.
Oral Contraceptives.
Hormones.
Biosimilars.
Nutraceuticals.
5
REGULATORY STATUS
Oct 2016
Renewal Audits
Apr 2017 Apr 2018 May 2018 Oct 2020 Oct 2021
Apr 2019 Jun 2022
Sep 2019 Aug 2022
Nov 2022
6
ORGANOGRAM
Board of Directors
ManagingDirector
Bioequivalence Administration Clinical Trial Quality Assurance
Clinical Bioanalytical
Clinical Laboratory Services
Human
Resource
Finance Project Management &
Business Development
Maintenance Information
Technology
Clinical Research
Associate
Monitors
Head Clinical Operation
7
OURCREW
Principal Investigator
Dr. K. Annamalai
8
Medical Officer
Dr. Gokul
Manager- Clinical
Mr. John Merlin Y S
Senior Manager - Bioanalytical
Mr. Vijaya Krishnan
HR Manager
Mrs. Rupa K P
Managing Director
Mrs. R. Abiraamasundari
Project Manager
Mrs. Latha Lakshmanan
&
Vignesh Kumar P. Ph.D.,
Manager – Quality Assurance
Mr. Immanuvel Manicaraj J
Lab Director
Dr. R. D. Puvitha
Consultant Pathologist
Dr. S. Aravinth
Quality Manager
Mrs. S. Revathi
9
INFRASTRUCTURE
Construction Area
44000 square feet with air conditioned facility for BA/BE studies.
Clinical Facility
 100 beds capacity divided in 8 clinical processing units
 OVIS software to identify cross participation of volunteers.
 Strong volunteer database of around 10,000 including male
and female.
 Inhouse Digital X-Ray facilities.
Quality Assurance
 Inhouse Quality Assurance department.
 Robust Quality systems with continuous audits facilitating
continual improvements.
 Data integrity is ensured through well written data governance
policies.
Emergency Facilities
 Round the clock power back-up.
 In-house ambulance services.
 In-house ICU facility with 4 beds. Cont.
10
INFRASTRUCTURE
Bioanalytical Facility
 3 LC-MS/MS which includes API 5500, API 4000, and
Shimadzu 8045.
 Seamless data transfer through software platform.
Archival Facilities
 Inhouse archival facility with fireproof compactors.
 Offsite Archival in 35 Kms away from site.
Clinical Laboratory Services
 NABL accredited clinical laboratory services.
 Automated LIMS connected systems.
 Seamless data transfer through LIMS software.
Information Technology
 Well equipped with 3 dedicated servers
11
OVERVIEWOF BA/ BE STUDIES
TOTAL NO. OF STUDIES : 285
TOTAL NO. OF VALIDATED METHODS: 300
Pivotal
EMA - 5
Pivotal
ROW - 5
Pivotal
UKMHRA - 2
Pivotal
USFDA - 12
Pivotal
WHO- 8
Pivotal
DCGI- 3
12
UNIQUE SELLINGPOINT
Delivering the projects in the
committed timeline.
Quality and Data integrity is
proven through two consecutive
successful USFDA inspection
with NIL 483
100 years of combined expert team in
conducting Phase I to Phase IV studies,
oncology trials, IITS, MMSS, PMSSS
and therapeutic equivalent studies
13
PROJECTTIMELINES FOR BA/ BE STUDIES
Clinical - Lit. Survey, Protocol
preparation and approval.
BA – Procurement of standards.
Clinical – Ethics committee approval.
P-I – check-in to washout.
BA – Method Development.
Clinical – P-II – check-in to washout.
BA – Method Validation.
Week 1
Week 2
Week 3
Week 4
Sample transfer & analysis
Week 5
Week 6
Report Compilation
Draft report sharing
Timeline for BA/BE pilot study with 12 subjects cross over study with24 Hrs. housing & 03 days wash out
Total time line to
complete the project
is 45 days
ADVANTAGE OF W
ORKING W
ITHUS
Quality
Good Output
Cost effective
Data Integrity
Timely delivery
14
OUR CLIENTS
15
REACHOUT TOUS
SPINOS LIFE SCIENCE AND RESEARCH PRIVATE LIMITED NO. 29
A, KRISHNA MADURA VANAM, VELLAKINAR PIRIVU, G. N. MILLS
POST, COIMBATORE, TAMILNADU, INDIA.
(+91 422- 4352491) (+91 9442143923)
info@spinoslifescience.com
www.spinoslifescience.com
SpinoS Life Science
16
SpinoS Corporate Presentation.pptx

Más contenido relacionado

Similar a SpinoS Corporate Presentation.pptx

Sitec Presentation 140915
Sitec Presentation 140915Sitec Presentation 140915
Sitec Presentation 140915Sitec Labs
 
Clinical Trials in India
Clinical Trials in IndiaClinical Trials in India
Clinical Trials in Indiavaatsalya
 
AXIS Clinicals Corporate Presentation
AXIS Clinicals Corporate PresentationAXIS Clinicals Corporate Presentation
AXIS Clinicals Corporate PresentationAxis Clinicals
 
Clinical Research, pharmacy,
Clinical Research, pharmacy, Clinical Research, pharmacy,
Clinical Research, pharmacy, Sneha Bansal
 
Optimizing the Output of Your Molecular Pathology Laboratory
Optimizing the Output of Your Molecular Pathology LaboratoryOptimizing the Output of Your Molecular Pathology Laboratory
Optimizing the Output of Your Molecular Pathology LaboratoryJosh Forsythe
 
Recent advances in pharmaceutical industry
Recent advances in pharmaceutical industryRecent advances in pharmaceutical industry
Recent advances in pharmaceutical industryAmitabh Tripathi
 
Group_3_M - Cancer Research Laboratory.pptx
Group_3_M - Cancer Research Laboratory.pptxGroup_3_M - Cancer Research Laboratory.pptx
Group_3_M - Cancer Research Laboratory.pptxNafeesaHanif1
 
Animal Production and Health
Animal Production and HealthAnimal Production and Health
Animal Production and Healthmzk57
 
TetraQ - Integrated Preclinical Drug Development Solutions Presentation
TetraQ - Integrated Preclinical Drug Development Solutions PresentationTetraQ - Integrated Preclinical Drug Development Solutions Presentation
TetraQ - Integrated Preclinical Drug Development Solutions Presentationguest55305
 
SCL Healthcare overview(220408).pptx
SCL Healthcare overview(220408).pptxSCL Healthcare overview(220408).pptx
SCL Healthcare overview(220408).pptxMuhammadIbnuHajar2
 
Covance Global Capabilities. #Covance
Covance Global Capabilities. #Covance Covance Global Capabilities. #Covance
Covance Global Capabilities. #Covance Andrea Miceli
 
WuXi Apptec lab testing division overview 2016
WuXi Apptec lab testing division overview 2016WuXi Apptec lab testing division overview 2016
WuXi Apptec lab testing division overview 2016Linda Zhao
 
Wu xi apptec lab testing division overview 2016
Wu xi apptec lab testing division overview 2016Wu xi apptec lab testing division overview 2016
Wu xi apptec lab testing division overview 2016Linda Zhao
 

Similar a SpinoS Corporate Presentation.pptx (20)

Sitec Presentation 140915
Sitec Presentation 140915Sitec Presentation 140915
Sitec Presentation 140915
 
Clinical Trials in India
Clinical Trials in IndiaClinical Trials in India
Clinical Trials in India
 
Opportunities in Clinical Research
Opportunities in Clinical ResearchOpportunities in Clinical Research
Opportunities in Clinical Research
 
Cr and opportunities by bhumika
Cr and opportunities by bhumikaCr and opportunities by bhumika
Cr and opportunities by bhumika
 
AXIS Clinicals Corporate Presentation
AXIS Clinicals Corporate PresentationAXIS Clinicals Corporate Presentation
AXIS Clinicals Corporate Presentation
 
Mtr corporate
Mtr corporateMtr corporate
Mtr corporate
 
Pyramid Laboratories Overview
Pyramid Laboratories OverviewPyramid Laboratories Overview
Pyramid Laboratories Overview
 
Clinical Research, pharmacy,
Clinical Research, pharmacy, Clinical Research, pharmacy,
Clinical Research, pharmacy,
 
Optimizing the Output of Your Molecular Pathology Laboratory
Optimizing the Output of Your Molecular Pathology LaboratoryOptimizing the Output of Your Molecular Pathology Laboratory
Optimizing the Output of Your Molecular Pathology Laboratory
 
Recent advances in pharmaceutical industry
Recent advances in pharmaceutical industryRecent advances in pharmaceutical industry
Recent advances in pharmaceutical industry
 
Group_3_M - Cancer Research Laboratory.pptx
Group_3_M - Cancer Research Laboratory.pptxGroup_3_M - Cancer Research Laboratory.pptx
Group_3_M - Cancer Research Laboratory.pptx
 
Efrac drug brochure
Efrac drug brochureEfrac drug brochure
Efrac drug brochure
 
Animal Production and Health
Animal Production and HealthAnimal Production and Health
Animal Production and Health
 
TetraQ - Integrated Preclinical Drug Development Solutions Presentation
TetraQ - Integrated Preclinical Drug Development Solutions PresentationTetraQ - Integrated Preclinical Drug Development Solutions Presentation
TetraQ - Integrated Preclinical Drug Development Solutions Presentation
 
SCL Healthcare overview(220408).pptx
SCL Healthcare overview(220408).pptxSCL Healthcare overview(220408).pptx
SCL Healthcare overview(220408).pptx
 
Covance Global Capabilities. #Covance
Covance Global Capabilities. #Covance Covance Global Capabilities. #Covance
Covance Global Capabilities. #Covance
 
WuXi Apptec lab testing division overview 2016
WuXi Apptec lab testing division overview 2016WuXi Apptec lab testing division overview 2016
WuXi Apptec lab testing division overview 2016
 
Wu xi apptec lab testing division overview 2016
Wu xi apptec lab testing division overview 2016Wu xi apptec lab testing division overview 2016
Wu xi apptec lab testing division overview 2016
 
GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES
 
QIAGEN - Press release
QIAGEN - Press releaseQIAGEN - Press release
QIAGEN - Press release
 

Último

Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsRizwan Syed
 
What's New in Teams Calling, Meetings and Devices March 2024
What's New in Teams Calling, Meetings and Devices March 2024What's New in Teams Calling, Meetings and Devices March 2024
What's New in Teams Calling, Meetings and Devices March 2024Stephanie Beckett
 
Vertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsVertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsMiki Katsuragi
 
Story boards and shot lists for my a level piece
Story boards and shot lists for my a level pieceStory boards and shot lists for my a level piece
Story boards and shot lists for my a level piececharlottematthew16
 
Install Stable Diffusion in windows machine
Install Stable Diffusion in windows machineInstall Stable Diffusion in windows machine
Install Stable Diffusion in windows machinePadma Pradeep
 
Powerpoint exploring the locations used in television show Time Clash
Powerpoint exploring the locations used in television show Time ClashPowerpoint exploring the locations used in television show Time Clash
Powerpoint exploring the locations used in television show Time Clashcharlottematthew16
 
Unraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdfUnraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdfAlex Barbosa Coqueiro
 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsMemoori
 
Vector Databases 101 - An introduction to the world of Vector Databases
Vector Databases 101 - An introduction to the world of Vector DatabasesVector Databases 101 - An introduction to the world of Vector Databases
Vector Databases 101 - An introduction to the world of Vector DatabasesZilliz
 
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticscarlostorres15106
 
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationBeyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationSafe Software
 
Human Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR SystemsHuman Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR SystemsMark Billinghurst
 
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Mark Simos
 
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024BookNet Canada
 
DevoxxFR 2024 Reproducible Builds with Apache Maven
DevoxxFR 2024 Reproducible Builds with Apache MavenDevoxxFR 2024 Reproducible Builds with Apache Maven
DevoxxFR 2024 Reproducible Builds with Apache MavenHervé Boutemy
 
My Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationMy Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationRidwan Fadjar
 
Ensuring Technical Readiness For Copilot in Microsoft 365
Ensuring Technical Readiness For Copilot in Microsoft 365Ensuring Technical Readiness For Copilot in Microsoft 365
Ensuring Technical Readiness For Copilot in Microsoft 3652toLead Limited
 
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024BookNet Canada
 
Dev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebDev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebUiPathCommunity
 

Último (20)

Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL Certs
 
What's New in Teams Calling, Meetings and Devices March 2024
What's New in Teams Calling, Meetings and Devices March 2024What's New in Teams Calling, Meetings and Devices March 2024
What's New in Teams Calling, Meetings and Devices March 2024
 
Vertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsVertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering Tips
 
Story boards and shot lists for my a level piece
Story boards and shot lists for my a level pieceStory boards and shot lists for my a level piece
Story boards and shot lists for my a level piece
 
Install Stable Diffusion in windows machine
Install Stable Diffusion in windows machineInstall Stable Diffusion in windows machine
Install Stable Diffusion in windows machine
 
Powerpoint exploring the locations used in television show Time Clash
Powerpoint exploring the locations used in television show Time ClashPowerpoint exploring the locations used in television show Time Clash
Powerpoint exploring the locations used in television show Time Clash
 
Unraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdfUnraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdf
 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial Buildings
 
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptxE-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
 
Vector Databases 101 - An introduction to the world of Vector Databases
Vector Databases 101 - An introduction to the world of Vector DatabasesVector Databases 101 - An introduction to the world of Vector Databases
Vector Databases 101 - An introduction to the world of Vector Databases
 
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
 
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationBeyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
 
Human Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR SystemsHuman Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR Systems
 
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
 
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
 
DevoxxFR 2024 Reproducible Builds with Apache Maven
DevoxxFR 2024 Reproducible Builds with Apache MavenDevoxxFR 2024 Reproducible Builds with Apache Maven
DevoxxFR 2024 Reproducible Builds with Apache Maven
 
My Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationMy Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 Presentation
 
Ensuring Technical Readiness For Copilot in Microsoft 365
Ensuring Technical Readiness For Copilot in Microsoft 365Ensuring Technical Readiness For Copilot in Microsoft 365
Ensuring Technical Readiness For Copilot in Microsoft 365
 
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
 
Dev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebDev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio Web
 

SpinoS Corporate Presentation.pptx

  • 2. To Be The Topmost Trusted Regulatory Compliant Clinical Research Organization VISION 2
  • 3. Touch base with at least 50 International Pharmaceutical Companies by 2028 Obtain UKMHRA/EMEA/GCC regulatory approvals in next five years of time 3 Exceed customer expectation in terms of quality and timeline. M ISSION
  • 4. OURSERVICES BIOAVAILABILITY / BIOEQUIVALENCE STUDIES CLINICAL TRIAL (Phase I to Phase IV) Real World Evidence Data collection & Registry Studies NUTRACEUTICAL TRIALS PROOF OF CONCEPT STUDIES MEDICAL DEVICE TRIALS 4
  • 5. THERAPEUTICS EXPERTISE Oncology. Anti-diabetic. Anti-viral. Anti – malarial. Anti-depreseant Anti-inflammatory. Anti-tubercular. Oral Contraceptives. Hormones. Biosimilars. Nutraceuticals. 5
  • 6. REGULATORY STATUS Oct 2016 Renewal Audits Apr 2017 Apr 2018 May 2018 Oct 2020 Oct 2021 Apr 2019 Jun 2022 Sep 2019 Aug 2022 Nov 2022 6
  • 7. ORGANOGRAM Board of Directors ManagingDirector Bioequivalence Administration Clinical Trial Quality Assurance Clinical Bioanalytical Clinical Laboratory Services Human Resource Finance Project Management & Business Development Maintenance Information Technology Clinical Research Associate Monitors Head Clinical Operation 7
  • 8. OURCREW Principal Investigator Dr. K. Annamalai 8 Medical Officer Dr. Gokul Manager- Clinical Mr. John Merlin Y S Senior Manager - Bioanalytical Mr. Vijaya Krishnan HR Manager Mrs. Rupa K P Managing Director Mrs. R. Abiraamasundari Project Manager Mrs. Latha Lakshmanan & Vignesh Kumar P. Ph.D., Manager – Quality Assurance Mr. Immanuvel Manicaraj J Lab Director Dr. R. D. Puvitha Consultant Pathologist Dr. S. Aravinth Quality Manager Mrs. S. Revathi
  • 9. 9 INFRASTRUCTURE Construction Area 44000 square feet with air conditioned facility for BA/BE studies. Clinical Facility  100 beds capacity divided in 8 clinical processing units  OVIS software to identify cross participation of volunteers.  Strong volunteer database of around 10,000 including male and female.  Inhouse Digital X-Ray facilities. Quality Assurance  Inhouse Quality Assurance department.  Robust Quality systems with continuous audits facilitating continual improvements.  Data integrity is ensured through well written data governance policies. Emergency Facilities  Round the clock power back-up.  In-house ambulance services.  In-house ICU facility with 4 beds. Cont.
  • 10. 10 INFRASTRUCTURE Bioanalytical Facility  3 LC-MS/MS which includes API 5500, API 4000, and Shimadzu 8045.  Seamless data transfer through software platform. Archival Facilities  Inhouse archival facility with fireproof compactors.  Offsite Archival in 35 Kms away from site. Clinical Laboratory Services  NABL accredited clinical laboratory services.  Automated LIMS connected systems.  Seamless data transfer through LIMS software. Information Technology  Well equipped with 3 dedicated servers
  • 11. 11 OVERVIEWOF BA/ BE STUDIES TOTAL NO. OF STUDIES : 285 TOTAL NO. OF VALIDATED METHODS: 300 Pivotal EMA - 5 Pivotal ROW - 5 Pivotal UKMHRA - 2 Pivotal USFDA - 12 Pivotal WHO- 8 Pivotal DCGI- 3
  • 12. 12 UNIQUE SELLINGPOINT Delivering the projects in the committed timeline. Quality and Data integrity is proven through two consecutive successful USFDA inspection with NIL 483 100 years of combined expert team in conducting Phase I to Phase IV studies, oncology trials, IITS, MMSS, PMSSS and therapeutic equivalent studies
  • 13. 13 PROJECTTIMELINES FOR BA/ BE STUDIES Clinical - Lit. Survey, Protocol preparation and approval. BA – Procurement of standards. Clinical – Ethics committee approval. P-I – check-in to washout. BA – Method Development. Clinical – P-II – check-in to washout. BA – Method Validation. Week 1 Week 2 Week 3 Week 4 Sample transfer & analysis Week 5 Week 6 Report Compilation Draft report sharing Timeline for BA/BE pilot study with 12 subjects cross over study with24 Hrs. housing & 03 days wash out Total time line to complete the project is 45 days
  • 14. ADVANTAGE OF W ORKING W ITHUS Quality Good Output Cost effective Data Integrity Timely delivery 14
  • 16. REACHOUT TOUS SPINOS LIFE SCIENCE AND RESEARCH PRIVATE LIMITED NO. 29 A, KRISHNA MADURA VANAM, VELLAKINAR PIRIVU, G. N. MILLS POST, COIMBATORE, TAMILNADU, INDIA. (+91 422- 4352491) (+91 9442143923) info@spinoslifescience.com www.spinoslifescience.com SpinoS Life Science 16